Israel Active

Scientists at Israel’s Ben Gurion University have discovered how cells control energy levels and have developed molecules that lowered blood glucose levels in lab tests. The scientists believe these could form the basis of tools to cure diabetes, cancer, and other metabolic disorders.

Researchers at the Hebrew University of Jerusalem, together with the IDF Medical Corps, have unveiled a new autoinjector that could drastically reduce deaths from severe bleeding. It delivers Tranexamic Acid (TXA) to stabilize blood clots and reduce blood loss.

Researchers from Tel Aviv University and Sourasky Medical Center (“Ichilov”) have measured patients’ memory just by tracking their eye movements as they watched animation videos. It can measure memory in subjects who cannot speak, such as infants, patients with brain injuries, or even animals.

Israel’s TruLeaf Medical (see previously) successfully implanted its RoseDoc docking device in two patients in India. It is the first step in a two-stage catheter-based procedure to replace faulty tricuspid and mitral valves, without open-heart surgery.

Researchers from Israel’s Ben Gurion University and in Harvard and Leipzog, have uncovered innovative biological evidence that diet can directly influence brain aging. The Good Mediterranean Diet reduced proteins Galectin-9 and Decorin, which were very high in degenerated brain ages.

Scientists from Tel Aviv University have introduced an innovative gene therapy method to treat impairments in hearing and balance caused by inner ear dysfunction. The research is featured in the EMBO Molecular Medicine magazine and highlighted on its cover.

Tel Aviv University researchers have developed a targeted method of delivering locked nucleic acids (LNAs) using lipid nanoparticles, achieving therapeutic effect against inflammatory bowel disease in preclinical models - without side effects. It could also be used for heart diseases, and Parkinson’s.

Prof. Abd Al-Roof Higazi of Hadassah Medical Center has developed ClearPlasma, a device that removes clot-dissolving proteins from donated plasma to quickly stop bleeding, His startup Plas-Free is now marketing ClearPlasma in Israel. Blood loss is the leading cause of death in under-45s.   

Israel’s NeuroKaire (previously Genetika+ see ) has launched BrightKaire, the world’s first blood test to personalize depression treatment. It uses AI and stem cell tech to match patients with major depressive disorder (MDD) to effective medications. Approved in US and Israel.

Members and supporters of Hadassah, The Women’s Zionist Organization of America, pledged $23 million for Hadassah Medical Organization, its Jerusalem medical center, as well as programs in Israel and the US. It includes $5 million for a neurorehabilitation center and $3 million for IVF.